North America Dry Eye Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The North America dry eye syndrome market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2023-2028. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Key Regions Analysed
United States
Canada
Analysis for Each Country
Market by Disease Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Market by Drug Type
Lubricant Eye Drops
Anti-inflammatory Drugs
Autologous Serum Eye Drops
Others
Market by Product
Liquid Drops
Gels
Liquid Wipes
Eye Ointments
Others
Market by Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
How has the North America dry eye syndrome market performed so far and how will it perform in the coming years?
What are the key regions in the North America dry eye syndrome market?
What has been the impact of COVID-19 on the North America dry eye syndrome market?
What is the breakup of the North America dry eye syndrome market on the basis of disease type?
What is the breakup of the North America dry eye syndrome market on the basis of drug type?
What is the breakup of the North America dry eye syndrome market on the basis of product?
What is the breakup of the North America dry eye syndrome market on the basis of distribution channel?
What are the various stages in the value chain of the North America dry eye syndrome industry?
What are the key driving factors and challenges in the North America dry eye syndrome industry?
What is the structure of the North America dry eye syndrome industry and who are the key players?
What is the degree of competition in the North America dry eye syndrome industry?
What are the profit margins in the North America dry eye syndrome industry?
The North America dry eye syndrome market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2023-2028. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Key Regions Analysed
United States
Canada
Analysis for Each Country
Market by Disease Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Market by Drug Type
Lubricant Eye Drops
Anti-inflammatory Drugs
Autologous Serum Eye Drops
Others
Market by Product
Liquid Drops
Gels
Liquid Wipes
Eye Ointments
Others
Market by Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
How has the North America dry eye syndrome market performed so far and how will it perform in the coming years?
What are the key regions in the North America dry eye syndrome market?
What has been the impact of COVID-19 on the North America dry eye syndrome market?
What is the breakup of the North America dry eye syndrome market on the basis of disease type?
What is the breakup of the North America dry eye syndrome market on the basis of drug type?
What is the breakup of the North America dry eye syndrome market on the basis of product?
What is the breakup of the North America dry eye syndrome market on the basis of distribution channel?
What are the various stages in the value chain of the North America dry eye syndrome industry?
What are the key driving factors and challenges in the North America dry eye syndrome industry?
What is the structure of the North America dry eye syndrome industry and who are the key players?
What is the degree of competition in the North America dry eye syndrome industry?
What are the profit margins in the North America dry eye syndrome industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL DRY EYE SYNDROME MARKET
5.1Market Performance
5.2Market Breakup by Disease Type
5.3Market Breakup by Drug Type
5.4Market Breakup by Product
5.5Market Breakup by Distribution Channel
5.6Market Breakup by Region
5.7Market Forecast
6 NORTH AMERICA DRY EYE SYNDROME MARKET
6.1Market Performance
6.2Impact of COVID-19
6.3Market Forecast
7 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISEASE TYPE
7.1Evaporative Dry Eye Syndrome
7.2Aqueous Dry Eye Syndrome
8 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DRUG TYPE
8.1Lubricant Eye Drops
8.2Anti-inflammatory Drugs
8.3Autologous Serum Eye Drops
8.4Others
9 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY PRODUCT
9.1Liquid Drops
9.2Gels
9.3Liquid Wipes
9.4Eye Ointments
9.5Others
10 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISTRIBUTION CHANNEL
10.1Retail Pharmacies
10.2Hospital Pharmacies
10.3Online Pharmacies
11 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY COUNTRY
11.1 United States
11.1.1Historical Market Trends
11.1.2Market Breakup by Disease Type
11.1.3Market Breakup by Drug Type
11.1.4Market Breakup by Product
11.1.5Market Breakup by Distribution Channel
11.1.6Market Forecast
11.2 Canada
11.2.1Historical Market Trends
11.2.2Market Breakup by Disease Type
11.2.3Market Breakup by Drug Type
11.2.4Market Breakup by Product
11.2.5Market Breakup by Distribution Channel
11.2.6Market Forecast
12 SWOT ANALYSIS
12.1Overview
12.2Strengths
12.3Weaknesses
12.4Opportunities
12.5Threats
13 VALUE CHAIN ANALYSIS
14 PORTER’S FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Rivalry
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1Market Structure
16.2Key Players
16.3Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL DRY EYE SYNDROME MARKET
5.1Market Performance
5.2Market Breakup by Disease Type
5.3Market Breakup by Drug Type
5.4Market Breakup by Product
5.5Market Breakup by Distribution Channel
5.6Market Breakup by Region
5.7Market Forecast
6 NORTH AMERICA DRY EYE SYNDROME MARKET
6.1Market Performance
6.2Impact of COVID-19
6.3Market Forecast
7 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISEASE TYPE
7.1Evaporative Dry Eye Syndrome
7.2Aqueous Dry Eye Syndrome
8 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DRUG TYPE
8.1Lubricant Eye Drops
8.2Anti-inflammatory Drugs
8.3Autologous Serum Eye Drops
8.4Others
9 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY PRODUCT
9.1Liquid Drops
9.2Gels
9.3Liquid Wipes
9.4Eye Ointments
9.5Others
10 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISTRIBUTION CHANNEL
10.1Retail Pharmacies
10.2Hospital Pharmacies
10.3Online Pharmacies
11 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY COUNTRY
11.1 United States
11.1.1Historical Market Trends
11.1.2Market Breakup by Disease Type
11.1.3Market Breakup by Drug Type
11.1.4Market Breakup by Product
11.1.5Market Breakup by Distribution Channel
11.1.6Market Forecast
11.2 Canada
11.2.1Historical Market Trends
11.2.2Market Breakup by Disease Type
11.2.3Market Breakup by Drug Type
11.2.4Market Breakup by Product
11.2.5Market Breakup by Distribution Channel
11.2.6Market Forecast
12 SWOT ANALYSIS
12.1Overview
12.2Strengths
12.3Weaknesses
12.4Opportunities
12.5Threats
13 VALUE CHAIN ANALYSIS
14 PORTER’S FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Rivalry
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1Market Structure
16.2Key Players
16.3Profiles of Key Players
LIST OF TABLES
Table 1: North America: Dry Eye Syndrome Market: Key Industry Highlights, 2022 and 2028
Table 2: North America: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 3: North America: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: North America: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 5: North America: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: North America: Dry Eye Syndrome Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 7: North America: Dry Eye Syndrome Market: Competitive Structure
Table 8: North America: Dry Eye Syndrome Market: Key Players
Table 1: North America: Dry Eye Syndrome Market: Key Industry Highlights, 2022 and 2028
Table 2: North America: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 3: North America: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: North America: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 5: North America: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: North America: Dry Eye Syndrome Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 7: North America: Dry Eye Syndrome Market: Competitive Structure
Table 8: North America: Dry Eye Syndrome Market: Key Players
LIST OF FIGURES
Figure 1: North America: Dry Eye Syndrome Market: Major Drivers and Challenges
Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 6: Global: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2022
Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: North America: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2017-2022
Figure 10: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 11: North America: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 12: North America: Dry Eye Syndrome (Evaporative Dry Eye Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: North America: Dry Eye Syndrome (Evaporative Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: North America: Dry Eye Syndrome (Aqueous Dry Eye Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: North America: Dry Eye Syndrome (Aqueous Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: North America: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 17: North America: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: North America: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: North America: Dry Eye Syndrome (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: North America: Dry Eye Syndrome (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: North America: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: North America: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: North America: Dry Eye Syndrome (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: North America: Dry Eye Syndrome (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 26: North America: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Dry Eye Syndrome (Gels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Dry Eye Syndrome (Gels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Dry Eye Syndrome (Eye Ointments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Dry Eye Syndrome (Eye Ointments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: North America: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: North America: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: North America: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 37: North America: Dry Eye Syndrome Market: Sales through Retail Pharmacies (in Million US$), 2017 & 2022
Figure 38: North America: Dry Eye Syndrome Market Forecast: Sales through Retail Pharmacies (in Million US$), 2023-2028
Figure 39: North America: Dry Eye Syndrome Market: Sales through Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 40: North America: Dry Eye Syndrome Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2023-2028
Figure 41: North America: Dry Eye Syndrome Market: Sales through Online Pharmacies (in Million US$), 2017 & 2022
Figure 42: North America: Dry Eye Syndrome Market Forecast: Sales through Online Pharmacies (in Million US$), 2023-2028
Figure 43: North America: Dry Eye Syndrome Market: Breakup by Country (in %), 2022
Figure 44: United States: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017-2022
Figure 45: United States: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 46: United States: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 47: United States: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 48: United States: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 49: United States: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Canada: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017-2022
Figure 51: Canada: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 52: Canada: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 53: Canada: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 54: Canada: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 55: Canada: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: North America: Dry Eye Syndrome Industry: SWOT Analysis
Figure 57: North America: Dry Eye Syndrome Industry: Value Chain Analysis
Figure 58: North America: Dry Eye Syndrome Industry: Porter’s Five Forces Analysis
Figure 1: North America: Dry Eye Syndrome Market: Major Drivers and Challenges
Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 6: Global: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2022
Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: North America: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2017-2022
Figure 10: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 11: North America: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 12: North America: Dry Eye Syndrome (Evaporative Dry Eye Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: North America: Dry Eye Syndrome (Evaporative Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: North America: Dry Eye Syndrome (Aqueous Dry Eye Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: North America: Dry Eye Syndrome (Aqueous Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: North America: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 17: North America: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: North America: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: North America: Dry Eye Syndrome (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: North America: Dry Eye Syndrome (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: North America: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: North America: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: North America: Dry Eye Syndrome (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: North America: Dry Eye Syndrome (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 26: North America: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Dry Eye Syndrome (Gels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Dry Eye Syndrome (Gels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Dry Eye Syndrome (Eye Ointments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Dry Eye Syndrome (Eye Ointments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: North America: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: North America: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: North America: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 37: North America: Dry Eye Syndrome Market: Sales through Retail Pharmacies (in Million US$), 2017 & 2022
Figure 38: North America: Dry Eye Syndrome Market Forecast: Sales through Retail Pharmacies (in Million US$), 2023-2028
Figure 39: North America: Dry Eye Syndrome Market: Sales through Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 40: North America: Dry Eye Syndrome Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2023-2028
Figure 41: North America: Dry Eye Syndrome Market: Sales through Online Pharmacies (in Million US$), 2017 & 2022
Figure 42: North America: Dry Eye Syndrome Market Forecast: Sales through Online Pharmacies (in Million US$), 2023-2028
Figure 43: North America: Dry Eye Syndrome Market: Breakup by Country (in %), 2022
Figure 44: United States: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017-2022
Figure 45: United States: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 46: United States: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 47: United States: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 48: United States: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 49: United States: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Canada: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017-2022
Figure 51: Canada: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 52: Canada: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 53: Canada: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 54: Canada: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 55: Canada: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: North America: Dry Eye Syndrome Industry: SWOT Analysis
Figure 57: North America: Dry Eye Syndrome Industry: Value Chain Analysis
Figure 58: North America: Dry Eye Syndrome Industry: Porter’s Five Forces Analysis
